The layoffs affect Swiss manufacturing facilities. Elsewhere, the FDA pushed back an approval deadline and a mid-stage study showed Novo’s amycretin helps regulate blood sugar.
Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3
HOT NEWS
Beyond Launch: 5 Ways Therapy Success Is Being Redefined
Download this White Paper to Learn More As the pharmaceutical landscape grows more competitive, launching…
تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك
California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…
Arab Newswire Provides Press Release Distribution in Arabic
Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…